Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in ...

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Cardiomyopathies currently have no cures, but many of these disorders are prime candidates for gene therapies. Treatments for ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...